Innovatus Life Sciences Acquisition registered with the SEC to offer 17.5 milion units at $10 each. No warrants are included in the offering.
The SPAC is targeting companies in the life sciences sector.
Innovatus is led by CEO and Chairman David Schiff, a partner at investment firm Innovatus Capital Partners since its inception in 2015.
The SPAC has applied for a Nasdaq listing under ILAC. Read more.
